Dopiopharm GmbH (Germany), an established company with many years of expertise in the areas of pharmaceutical quality management and marketing consulting, is expanding its portfolio with its first own cannabis products. This is made possible by an exclusive supply contract with the renowned traditional company Tikun Olam (Greece).

The cannabis products are produced and cultivated at Tikun Olam S.A. in Athens. The ultra-modern production plant is EU-GMP certified and therefore meets the highest quality standards. In Greece, cannabis products are considered finished medicines and require regulatory approval, which provides additional quality assurance through strict controls.

As a quality management specialist, Dopiopharm itself assumes responsibility for the quality control of the products. For sales, Canify AG, an industry expert who has comprehensive expertise in this area.

With this partnership and its commitment to the highest quality, Dopiopharm GmbH is setting new standards in the area of medical cannabis products.